Sharechat Logo

While you were sleeping US retail sales disappoint

Tuesday 17th July 2012

Text too small?

Wall Street fell as US retail sales declined for a third straight month, while the International Monetary Fund reduced its forecasts for worldwide growth.

The global economy will expand 3.9 percent next year, which is down from the 4.1 percent pace it predicted in April, the IMF said in its latest World Economic Outlook. It kept its forecast for 2012 growth at 3.5 percent.

The fund forecast that Spain's economy will contract 0.6 percent next year, compared with its previous estimate for 0.1 percent growth. And the euro zone problems pose the biggest threat, the IMF said.

"Downside risks to this weaker global outlook continue to loom large," according to the IMF. "The most immediate risk is still that delayed or insufficient policy action will further escalate the euro area crisis."

Data today showed another clear sign of trouble in the world's largest economy as US retail sales dropped 0.5 percent in June, posting the longest run of monthly consecutive declines since 2008.

"This is another example of how broader economic uncertainty is having an impact on economic activity," Eric Fine, managing director of Van Eck G-175 strategies in New York, told Reuters.

The IMF kept its estimate for the US pace of expansion at 2 percent this year and 2.3 percent in 2013, as forecast July 3. Among results released today were those of Citigroup. Shares of the third-largest US bank gained more than 1 percent after its second-quarter profit surpassed expectations.

In late afternoon trading in New York, the Dow Jones Industrial Average fell 0.24 percent¸ the Standard & Poor's 500 Index slipped 0.11 percent, and the Nasdaq Composite Index shed 0.26 percent.

Among stocks gaining was Human Genome Sciences as GlaxoSmithKline agreed to acquire its long-time partner after a sweetened offer of US$3 billion.

Shares of Human Genome rose more than 4 percent. In another healthcare deal, private equity firm TPG said it would buy US-based Par Pharmaceutical for US$1.9 billion. Par shares soared more than 36 percent. In Europe the Stoxx 600 Index ended the day with a 0.2 percent gain for the session.

Euro zone inflation data, holding steady at 2.4 percent in June, underpinned the appeal of German bunds.

Germany's two-year yield fell one basis point to minus 0.055 percent after earlier declining to a record-low minus 0.06 percent, according to Bloomberg, while the three-year yield dropped as low as minus 0.022 percent, and the five-year rate hit a record low 0.27 percent.

"The general economic backdrop is poor, so people can't get too excited about the periphery," Eric Wand, a fixed-income strategist at Lloyds Banking Group in London, told Bloomberg News.

"General risk sentiment is keeping the core underpinned and investors are looking to rotate through the core and semi-core to find yield."

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report